St. Jude Medical (STJ) Announced FDA Approval of its Cool Point Irrigation Pump
More News related to STJ
- Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement
- St. Jude Medical To Present at the 2009 Credit Suisse Healthcare Conference
- Don't Miss Out! The Registration Period for the 2010 IR Global Rankings Ends TOMORROW!
- Time Is Running Out to Have Your IR Program Independently Evaluated!
- St. Jude Medical (STJ) Announces $500M Share Buyback
More News related to FDA
- S&P Announces Change to US Index: LL for UCBH
- Electronic Arts (ERTS) Makes Major Job Cuts As Q2 Profits Lag
- Kraft (KFT) to Ask Holders to Vote to Issue New Shares
- Sprint Nextel (S) Aims to Reduce Labor Costs by $350M in Q409
- Highlights From DISH's Q3 Conference Call - Q&A Session
St. Jude Medical, Inc. (NYSE: STJ) announced FDA approval of its Cool Point Irrigation Pump. Used in conjunction with SJM open-irrigated ablation catheters, an irrigation pump supplies a continuous flow of saline through the catheter's inner lumen to cool the ablation electrode for more effective energy delivery. Designed to enhance physicians' ability to perform successful atrial ablations, the new Cool Point irrigation pump was developed specifically for use with the company's IBI-1500T9-CP cardiac ablation generator and family of Therapy(TM) Cool Path(TM) irrigated catheters.
Related Categories
FDAStocks Mentioned
+0.44Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
